Description:
Pimavanserin is a potent and selective serotonin 5-HT2A inverse agonist. It has been used as an atypical antipsychotic in the treatment of psychosis associated with Parkinson's disease.
- Molecular Weight: 1005.2
- Molecular Formula: C50H68F2N6O4·C4H6O6
Canonical SMILES:
CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.C(C(C(=O)O)O)(C(=O)O)O
InChI:
InChI=1S/2C25H34FN3O2.C4H6O6/c2*1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21;5-1(3(7)8)2(6)4(9)10/h2*4-11,19,23H,12-18H2,1-3H3,(H,27,30);1-2,5-6H,(H,7,8)(H,9,10)/t;;1-,2-/m..1/s1
InChIKey: RGSULKHNAKTFIZ-CEAXSRTFSA-N- Application: Antiparkinson Agents
Synonyms:
ACP-103; Nuplazid1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea tartrate
More details are to be found on supplier website
